Danone
Global foods and beverages company
CDI – Senior Scientist Enzyme Technology - w/m
About the job
- Demonstrated experience applying enzymes within complex food matrices, including dairy and plant-based systems, to deliver targeted product functionalities.
- Strong understanding of enzyme–substrate interactions in heterogeneous and multi-component food environments.
- Proven capability to translate enzymatic activity into measurable product outcomes such as improved texture, flavor, stability, and overall product quality.
- Experience leading scientific projects and developing enzyme products or technologies.
- Experience managing or mentoring scientists or technicians.
- Ability to work cross-functionally and convert technical insights into business impact.
- Ability to connect internal teams and suppliers to work efficiently toward shared objectives.
- Strategic thinking with a hands-on problem-solving approach.
- Ability to coordinate the enzyme technology ecosystem internally and externally.
- At least 7 years of experience in enzyme research and development, industrial biotechnology, or related fields.
- Guide the development of enzyme-based solutions for product development and innovation.
- Evaluate new technologies and integrate them into research and development pipelines.
- Provide expert input on enzyme function and product–process interactions to product developers and other functions.
- Collaborate with the analytical science team to identify tools and methodologies.
- Act as technical lead or project lead in cross-functional project teams including Fermentation, Downstream Processing, Analytics, Application Technology, Regulatory, and Product Management.
- Translate business needs into technical workstreams and ensure timely delivery of milestones.
- Contribute to portfolio strategy, capability building, and technology roadmaps.
- Manage, mentor, and develop a team of scientists and technicians working in enzyme technology.
- Act as a key point of contact for enzyme suppliers and foster strategic, long-term technical partnerships.
- Collaborate with academic partners, contract research organizations, technology providers, and ingredient or enzyme suppliers.
- Scout emerging trends in enzyme technology.
- Support patent strategy and preparation of intellectual property filings to protect innovations.
- Industry experience in food ingredients, industrial biotechnology, or enzyme suppliers.
About the company
Danone is a global food and beverage company with three main divisions: Essential Dairy & Plant-Based products, Waters, and Specialized Nutrition. It markets brands like Actimel, Activia, Alpro, Evian, Nutricia, and Volvic across more than 120 countries with over 100,000 employees. Its products aim to support health through everyday nutrition and hydration, including dairy, plant-based options, and infant nutrition. The company pursues social and environmental goals under the One Planet. One Health framework and seeks B Corp certification by 2025, differentiating itself through a mission-driven approach and broad sustainability commitments.
Company Size
10,001+
Company Stage
IPO
Headquarters
Paris, France
Founded
1919
Get referred to Danone
See people who can refer or advise you
Simplify's Take
What believers are saying
- Danone reported first-half 2026 sales of €13.94 billion, up 3.5% like-for-like.
- Danone lifted recurring operating margin to 13.3% in H1 2026 and reaffirmed guidance.
- Danone issued September 2026 bonds and closed Huel, extending maturity and category growth.
What critics are saying
- Danone faces Chobani litigation from June and July 2026 over protein claims and packaging.
- Danone’s Bridgeton, New Jersey plant closure cuts 100-plus jobs and disrupts plant-based supply.
- Argentina’s deconsolidation and Mastellone debt create execution risk through 2026 integration and refinancing.
What makes Danone unique
- Danone owns health-led brands across dairy, waters, and specialized nutrition in 120 markets.
- Danone closed Huel on September 4, 2026, strengthening functional nutrition and DTC execution.
- Danone’s March 24, 2026 Argentina joint venture with Arcor reshapes local scale and control.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Wellness Program
Life Insurance
401(k) Retirement Plan
Parental Leave
Paid Vacation
Flexible Work Hours
Remote Work Options
Hybrid Work Options
Family Planning Benefits
Fertility Treatment Support
Childcare Support
Meal Benefits
Professional Development Budget
Training Programs
Conference Attendance Budget
Tuition Reimbursement
Gym Membership
Growth & Insights and Company News
6 month growth
↑ 11%1 year growth
↑ 12%2 year growth
↑ 12%Danone has issued a triple-tranche bond totaling €1.5 billion to support liquidity management and extend its debt maturity profile. The offering comprises three €500 million tranches: 18-month notes with a floating coupon of 3-month Euribor +0.30%, 5-year notes with a 4.0910% fixed coupon, and 9-year notes with a 4.4180% fixed coupon. Settlement is expected on 28 September 2026, with listing on Euronext Paris. The company said the bond issue was widely subscribed by a diversified investor base. Danone is rated BBB+ with stable outlook by Standard & Poor's and Baa1 with stable outlook by Moody's. The food and beverage company generated €27.3 billion in sales in 2025.
Arcor and Danone have injected $30 million into Mastellone Hermanos to cancel bank debt, less than a month after taking joint control of the Argentine dairy company. The funds come from La Serenísima Unida, the vehicle both groups created to consolidate the business, and will be applied as an irrevocable contribution towards future share subscription. The capital injection arrives at a critical time for Mastellone. In the first half of the year, La Serenísima reported losses of 4.79 billion pesos, compared to 1.16 billion pesos in the same period the previous year. The company also showed financial debts of around 259.19 billion pesos. The new joint venture combines Mastellone's milk, cheese, and butter operations with Danone Argentina's yoghurt and dessert business, aiming to achieve greater scale and efficiency in a challenging market environment.
Danone reported Q2 2026 sales up 4.2% on a like-for-like basis, with volume/mix increasing 1.9% and price rising 2.3%. The EMEA region grew 3.6%, Americas 4.3%, and APAC 5.2%, driven by competitive performance in China's infant milk formula and strong aqua waters results. For the first half of 2026, sales reached €13.94 billion, up 3.5% like-for-like. Recurring operating margin improved 12 basis points to 13.3%, supported by productivity gains despite inflation. Recurring earnings per share rose 0.9% to €1.92, whilst free cash flow totalled €0.9 billion. The company confirmed its 2026 guidance, expecting like-for-like sales growth between 3% and 5%, with recurring operating income growing faster than sales. Danone recently signed agreements to acquire Huel and Made Group in APAC.
Press release – Paris, June 22, 2026, 6:00 AM CEST Danone to acquire MADE Group, expanding its presence in the fast-growing healthy nutrition space in...
Danone's shareholders approved all resolutions at the company's 2026 annual meeting, with 73.08% of total outstanding share capital present or represented. Shareholders backed the 2025 financial statements and a dividend of €2.25 per share in cash, up 4.7% year-on-year. The ex-dividend date is 4 May 2026, with payment on 6 May 2026. The meeting also approved the renewal of terms for Gilles Schnepp as chairman of the board, Valérie Chapoulaud-Floquet as lead independent director, and Sanjiv Mehta. Danone presented its sustainability roadmap, the Danone Impact Journey, and outlined ambitions towards 2030, including its climate strategy. The board continued its global employee share subscription programme, allowing eligible employees in 48 countries to subscribe to new shares at a 30% discount.